Skip to main content

Table 1 Patient characteristics (cohort II and CD*)

From: Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56dim natural killer cells

Characteristic Value
Patients with GPA, n 22
Men/women, n 14/8
GPA in remission, n (%) 12/22 (55 %)
 Age in years, median (range) 55.5 (35–79)
 Duration of remission in years  (of inactive GPA), mean (range) 4.4 (1–20)
GPA non remission (active), n (%) 10/22 (45 %)
 Age in years, median (range) 51.5 (33–64)
 BVAS, mean (range) 4.5 (0–19)
Localized GPA (upper airways and ENT organs only), n (%) 4/22 (18 %)
Generalized GPA, n (%) 18/22 (82 %)
ANCA  
 Positive 17/22 (77 %)
 Negative 3/22 (14 %)
 Not determinable 2/28 (9 %)
Patients with CD, n 12
Men/women, n 3/9
  1. GPA granulomatosis with polyangiitis, BVAS Birmingham vasculitis activity score, ENT ear, nose and throat, ANCA antineutrophil cytoplasmic antibody, CD* inactive systemic inflammatory control diseases other than GPA comprising systemic lupus erythematosus (n = 4), panarteriitis nodosa (n = 1), overlap connective tissue disease (n = 1), chronic inflammatory bowel disease (n = 1), CREST syndrome (n = 1), primary Sjögren’s syndrome (n = 1), polymyalgia rheumatica (n = 1) and giant cell arteriitis (n = 2)